Literature DB >> 21217079

Notch is oncogenic dominant in T-cell acute lymphoblastic leukemia.

Renée M Demarest1, Nadia Dahmane, Anthony J Capobianco.   

Abstract

T-cell acute lymphoblastic leukemia (T-ALL) is a hematologic neoplasm characterized by malignant expansion of immature T cells. Activated NOTCH (Notch(IC)) and c-MYC expression are increased in a large percentage of human T-ALL tumors. Furthermore, c-MYC has been shown to be a NOTCH target gene. Although activating mutations of Notch have been found in human T-ALL tumors, there is little evidence that the c-MYC locus is altered in this neoplasm. It was previously demonstrated that Notch and c-Myc-regulated genes have a broadly overlapping profile, including genes involved in cell cycle progression and metabolism. Given that Notch and c-Myc appear to function similarly in T-ALL, we sought to determine whether these two oncogenes could substitute for each other in T-ALL tumors. Here we report that NOTCH(IC) is able to maintain T-ALL tumors formed in the presence of exogenous NOTCH(IC) and c-MYC when exogenous c-MYC expression is extinguished. In contrast, c-MYC is incapable of maintaining these tumors in the absence of NOTCH(IC). We propose that failure of c-MYC to maintain these tumors is the result of p53-mediated apoptosis. These results demonstrate that T-ALL maintenance is dependent on NOTCH(IC), but not c-MYC, demonstrating that NOTCH is oncogenic dominant in T-ALL tumors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217079      PMCID: PMC3062300          DOI: 10.1182/blood-2010-05-286351

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  43 in total

1.  Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.

Authors:  Andrew P Weng; Adolfo A Ferrando; Woojoong Lee; John P Morris; Lewis B Silverman; Cheryll Sanchez-Irizarry; Stephen C Blacklow; A Thomas Look; Jon C Aster
Journal:  Science       Date:  2004-10-08       Impact factor: 47.728

2.  Prethymic phenotype and genotype of pre-T (CD7+/ER-)-cell leukemia and its clinical significance within adult acute lymphoblastic leukemia.

Authors:  E Thiel; B R Kranz; A Raghavachar; C R Bartram; H Löffler; D Messerer; A Ganser; W D Ludwig; T Büchner; D Hoelzer
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

3.  Characterization of a high-molecular-weight Notch complex in the nucleus of Notch(ic)-transformed RKE cells and in a human T-cell leukemia cell line.

Authors:  Shawn Jeffries; David J Robbins; Anthony J Capobianco
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.

Authors:  J Cheng; M Haas
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

5.  Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.

Authors:  Ching-Hon Pui; John T Sandlund; Deqing Pei; Dario Campana; Gaston K Rivera; Raul C Ribeiro; Jeffrey E Rubnitz; Bassem I Razzouk; Scott C Howard; Melissa M Hudson; Cheng Cheng; Larry E Kun; Susana C Raimondi; Frederick G Behm; James R Downing; Mary V Relling; William E Evans
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

6.  Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis.

Authors:  Levi J Beverly; Anthony J Capobianco
Journal:  Cancer Cell       Date:  2003-06       Impact factor: 31.743

7.  The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice.

Authors:  J M Adams; A W Harris; C A Pinkert; L M Corcoran; W S Alexander; S Cory; R D Palmiter; R L Brinster
Journal:  Nature       Date:  1985 Dec 12-18       Impact factor: 49.962

8.  Roles for c-Myc in self-renewal of hematopoietic stem cells.

Authors:  Yusuke Satoh; Itaru Matsumura; Hirokazu Tanaka; Sachiko Ezoe; Hiroyuki Sugahara; Masao Mizuki; Hirohiko Shibayama; Eri Ishiko; Jun Ishiko; Koichi Nakajima; Yuzuru Kanakura
Journal:  J Biol Chem       Date:  2004-04-02       Impact factor: 5.157

9.  TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.

Authors:  L W Ellisen; J Bird; D C West; A L Soreng; T C Reynolds; S D Smith; J Sklar
Journal:  Cell       Date:  1991-08-23       Impact factor: 41.582

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  18 in total

1.  NOTCH1 regulates migration and invasion of skin cancer cells by E-cadherin repression.

Authors:  Zhipeng Wang; Linna Liu; Meng Wang; Min Shen; Jing Li; Juanjuan Liu; Chen Li; Chunyan Xin; Shaojun Zhu; Qibing Mei; Yukun Wang
Journal:  Mol Cell Biochem       Date:  2011-10-29       Impact factor: 3.396

Review 2.  How to Choose a Mouse Model of Breast Cancer, a Genomic Perspective.

Authors:  Matthew R Swiatnicki; Eran R Andrechek
Journal:  J Mammary Gland Biol Neoplasia       Date:  2019-06-21       Impact factor: 2.673

Review 3.  Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.

Authors:  Hudan Liu; Mark Y Chiang; Warren S Pear
Journal:  Int J Hematol       Date:  2011-08-05       Impact factor: 2.490

4.  Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.

Authors:  Rebecca Kohnken; Jing Wen; Bethany Mundy-Bosse; Kathleen McConnell; Ashleigh Keiter; Leah Grinshpun; Alex Hartlage; Max Yano; Betina McNeil; Nitin Chakravarti; Basem William; James E Bradner; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

5.  Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia.

Authors:  Pablo Iglesias; Ann-Christin Puller; Marcos Seoane; Michael Spohn; Sabine Raasch; Marianne Klokow; Jürgen Müller; Lia Burkhardt; Daniela Indenbirken; Martin A Horstmann
Journal:  Blood Adv       Date:  2021-03-09

6.  Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.

Authors:  Lesley A Rakowski; Derek D Garagiola; Choi M Li; Margaret Decker; Sarah Caruso; Morgan Jones; Rork Kuick; Tomasz Cierpicki; Ivan Maillard; Mark Y Chiang
Journal:  Cancer Res       Date:  2012-11-16       Impact factor: 12.701

7.  c-Myc inhibition prevents leukemia initiation in mice and impairs the growth of relapsed and induction failure pediatric T-ALL cells.

Authors:  Justine E Roderick; Jessica Tesell; Leonard D Shultz; Michael A Brehm; Dale L Greiner; Marian H Harris; Lewis B Silverman; Stephen E Sallan; Alejandro Gutierrez; A Thomas Look; Jun Qi; James E Bradner; Michelle A Kelliher
Journal:  Blood       Date:  2014-01-06       Impact factor: 22.113

8.  Activated Notch1 induces lung adenomas in mice and cooperates with Myc in the generation of lung adenocarcinoma.

Authors:  Thaddeus D Allen; Elena M Rodriguez; Kirk D Jones; J Michael Bishop
Journal:  Cancer Res       Date:  2011-07-29       Impact factor: 12.701

9.  NACK is an integral component of the Notch transcriptional activation complex and is critical for development and tumorigenesis.

Authors:  Kelly L Weaver; Marie-Clotilde Alves-Guerra; Ke Jin; Zhiqiang Wang; Xiaoqing Han; Prathibha Ranganathan; Xiaoxia Zhu; Thiago DaSilva; Wei Liu; Francesca Ratti; Renee M Demarest; Cristos Tzimas; Meghan Rice; Rodrigo Vasquez-Del Carpio; Nadia Dahmane; David J Robbins; Anthony J Capobianco
Journal:  Cancer Res       Date:  2014-07-18       Impact factor: 12.701

10.  Notch activation as a driver of osteogenic sarcoma.

Authors:  Jianning Tao; Ming-Ming Jiang; Lichun Jiang; Jason S Salvo; Huan-Chang Zeng; Brian Dawson; Terry K Bertin; Pulivarthi H Rao; Rui Chen; Lawrence A Donehower; Francis Gannon; Brendan H Lee
Journal:  Cancer Cell       Date:  2014-09-08       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.